Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Dyax Corp | 35 |
| 2 | University of California, San Diego | 22 |
| 3 | Agouron Pharmaceuticals LLC | 19 |
| 4 | Yale University | 19 |
| 5 | University of California Berkeley | 15 |
| 6 | University of Pennsylvania | 15 |
| 7 | Genelabs Technologies Inc | 14 |
| 8 | Dako Denmark ApS | 12 |
| 9 | University of California | 12 |
| 10 | Fujirebio Europe NV SA | 11 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | C07K | Peptides | 372 |
| 2 | G01N | Investigating / analysing materials | 286 |
| 3 | A61K | Medicinal preparations | 262 |
| 4 | C12N | Microorganisms, enzymes | 250 |
| 5 | A61P | Therapeutic activity (drug indications) | 224 |
| 6 | C12Q | Measuring/testing involving enzymes | 190 |
| 7 | Y10S | Cross-reference (legacy) | 76 |
| 8 | C40B | 61 | |
| 9 | C07D | Heterocyclic compounds | 47 |
| 10 | Y10T | Cross-reference (technical subjects) | 45 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Janos Zempleni | University of Nebraska–Lincoln | 3 |
| 2 | A. Neil Barclay | University of Oxford | 1 |
| 3 | Amanda B. Spurdle | QIMR Berghofer Medical Research Institute | 2 |
| 4 | Avadhesha Surolia | National Institute of Immunology | 2 |
| 5 | Logan C. Walker | QIMR Berghofer Medical Research Institute | 2 |
| 6 | Min Jee Kwon | Yonsei University | 1 |
| 7 | Nicola Waddell | QIMR Berghofer Medical Research Institute | 2 |
| 8 | Pat Kumar | Manchester Metropolitan University | 1 |
| 9 | Sean M. Grimmond | The University of Queensland | 2 |
| 10 | Sudha Purushothaman | Indian Institute of Science Bangalore | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Global Sequencing of Proteolytic Cleavage Sites in Apoptosis by Specific Labeling of Protein N Termini | 2008 | 467 | Cell death mechanisms and regulation |
| Biotinylation reagents for the study of cell surface proteins | 2008 | 207 | Cellular transport and secretion |
| Botulinum Neurotoxin Detection and Differentiation by Mass Spectrometry | 2005 | 186 | Neurological disorders and treatments |
| Biotin−Streptavidin-Induced Aggregation of Gold Nanorods: Tuning Rod−Rod Orientation | 2005 | 161 | Gold and Silver Nanoparticles Synthesis and Applications |
| Design of Luminescent Biotinylation Reagents Derived from Cyclometalated Iridium(III) and Rhodium(III) Bis(pyridylbenzaldehyde) Complexes | 2010 | 138 | Advanced biosensing and bioanalysis techniques |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of this compound?
How many patents and papers are associated with this compound?
Which organizations hold the most patents related to this compound?
What are the primary CPC classifications for patents mentioning this compound?
What research topics are associated with papers on this compound?